ESH Meeting Highlights 2006

 
Click on the dates to see the daily articles!
June 13

More patients reach goal blood pressures when GPs receive guideline treatment: VALNORM study

 

... continued from previous page

The VALNORM study was presented as a poster today at the 16th European Meeting of Hypertension in Madrid, Spain (abstract).

The 4,436 patients (52% women, 61 years old on average) had hypertension an average of 4 years and 50% were untreated at baseline and about 35% were receiving monotherapy. Average blood pressure levels at baseline were 160/92 mmHg, and about 13% had diabetes. About 54% had 1 or 2 risk factors without target organ damage, diabetes, or other associated disease. In this PROBE design study, of the 1,097 physicians, 502 received training in the 2003 ESH hypertension management guidelines including strict guidance for prescription choices from 4 weeks onward based on previous treatment, blood pressure measurements, and whether or not blood pressure control had been achieved. The other physicians were free in their prescription selections.

At week 8, nearly 48% of patients treated by the physicians trained in the guidelines had achieved control of both systolic and diastolic blood pressures, compared to 44% of patients treated by the untrained physicians. Of the patients with diabetes, 18% had achieved controlled systolic and diastolic BPs with the trained physicians, compared to 11% with the untrained physicians. Multivariate analysis showed that training of the physicians was positively related to the better blood pressure control.

DAILY WEBCASTS
WORKSHOP 1
Optimizing suppression of the renin-angiotensin-aldosterone system
JOINT SESSION ESH-ASH
PLENARY SESSION - AUDITORIUM
TEACHING SEMINAR 1 - WORKGROUP 8
Legal
The materials presented here were prepared by independent authors under the editorial supervision of ESHonline, and do not represent a publication of the European Society of Hypertension. These materials and the related activity are not sanctioned by the European Society of Hypertension and do not constitute an official part of that conference. These materials may discuss uses and dosages for therapeutic products that have not been approved by the nationals and internationals Laws. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © ESHonline.org.